163.42 USD
0.00
0%
At close Updated Nov 12, 4:00 PM EST
Pre-market
After hours
163.42
0.00
0%
1 day
0%
5 days
-0.18%
1 month
-12.16%
3 months
-3.35%
6 months
16.55%
Year to date
-23.14%
1 year
-23.01%
5 years
-12.52%
10 years
145.93%
 

About: Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Employees: 39,800

0
Funds holding %
of 7,516 funds
0
Analysts bullish %
of 6 analysts
0
Positive news %
of 7 articles
Price charts implemented using Lightweight Charts™